2022-RA-249-ESGO Overall survival results from ariel3: a phase 3 randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma

Robert L Coleman; Amit M Oza; Domenica Lorusso; Carol Aghajanian; Ana Oaknin; Andrew Dean; Nicoletta Colombo; Johanne I Weberpals; Andrew R Clamp; Giovanni Scambia; Alexandra Leary; Robert W Holloway; Margarita Amenedo Gancedo; Peter C Fong; Jeffrey C Goh; David M O’Malley; Sandra Goble; Lara Maloney; Jonathan A Ledermann

doi:10.1136/ijgc-2022-ESGO.488

Article info

Ovarian cancer

2022-RA-249-ESGO Overall survival results from ariel3: a phase 3 randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma

Free

Authors

Robert L Coleman Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX *current location: US Oncology Research, The Woodlands, TX PubMed articles Google scholar articles
Amit M Oza Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada PubMed articles Google scholar articles
Domenica Lorusso MITO and Gynecologic Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy PubMed articles Google scholar articles
Carol Aghajanian Gynecologic Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY PubMed articles Google scholar articles
Ana Oaknin Gynaecologic Cancer Programme, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebron, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain PubMed articles Google scholar articles
Andrew Dean Department of Oncology, St John of God Subiaco Hospital, Subiaco, WA, Australia PubMed articles Google scholar articles
Nicoletta Colombo Gynecologic Cancer Program, European Institute of Oncology and University of Milan-Bicocca, Milan, Italy PubMed articles Google scholar articles
Johanne I Weberpals Division of Gynecologic Oncology, Ottawa Hospital Research Institute, Ottawa, ON, Canada PubMed articles Google scholar articles
Andrew R Clamp Department of Medical Oncology, The Christie NHS Foundation Trust and University of Manchester, Manchester, UK PubMed articles Google scholar articles
Giovanni Scambia Fondazione Policlinico Universitario A. Gemelli IRCCS and Scientific Directorate, Rome, Italy PubMed articles Google scholar articles
Alexandra Leary Gynecological Unit, Gustave Roussy Cancer Center, INSERM U981, and Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens (GINECO), Villejuif, France PubMed articles Google scholar articles
Robert W Holloway Department of Gynecologic Oncology, Florida Hospital Cancer Institute, Orlando, FL PubMed articles Google scholar articles
Margarita Amenedo Gancedo Medical Oncology Department, Oncology Center of Galicia, La Coruña, Spain PubMed articles Google scholar articles
Peter C Fong Medical Oncology Department, Auckland City Hospital, Grafton, Auckland, New Zealand PubMed articles Google scholar articles
Jeffrey C Goh Department of Oncology, Cancer Care Services, Royal Brisbane and Women’s Hospital, Herston, QLD, Australia, and University of Queensland, St Lucia, QLD, Australia PubMed articles Google scholar articles
David M O’Malley Clinical Research Gynecologic Oncology, The Ohio State University, James Cancer Center, Columbus, OH PubMed articles Google scholar articles
Sandra Goble Biostatistics, Clovis Oncology, Inc., Boulder, CO PubMed articles Google scholar articles
Lara Maloney Clinical Development, Clovis Oncology, Inc., Boulder, CO PubMed articles Google scholar articles
Jonathan A Ledermann Department of Oncology, UCL Cancer Institute, University College London and UCL Hospitals, London, UK PubMed articles Google scholar articles

Citation

Coleman RL, Oza AM, Lorusso D, et al

International Journal of Gynecologic Cancer 2022;32:A226.

Publication history

First published October 20, 2022.

Online issue publication

October 27, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password